Investigations on pharmacokinetics and biodistribution of polymeric and solid lipid nanoparticulate systems of atypical antipsychotic drug: effect of material used and surface modification

References

• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329–47.
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86:215–23.
   PubMed Web of Science ®Google Scholar
• Takakura Y, Hashida M. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm Res 1996;13:820–31.
   PubMed Web of Science ®Google Scholar
• Benet LZ, Kroetz D, Sheiner L, et al. Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination. Goodman and Gilman's the Pharmacological Basis of Therapeutics 1996;1:3–27.
   Google Scholar
• Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood–brain barrier by nanoparticles. J Control Release 2012;161:264–73.
   PubMed Web of Science ®Google Scholar
• Snehalatha M, Kolachina V, Saha RN, et al. Enhanced tumor uptake, biodistribution and pharmacokinetics of etoposide loaded nanoparticles in Dalton's lymphoma tumor bearing mice. J Pharm Bioallied Sci 2013;5:290.
   PubMedGoogle Scholar
• Ribeiro HS, Chu BS, Ichikawa S, Nakajima M. Preparation of nanodispersions containing β-carotene by solvent displacement method. Food Hydrocoll 2008;22:12–17.
   Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–96.
   PubMed Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm 1999;25:471–6.
   PubMed Web of Science ®Google Scholar
• Martins S, Tho I, Reimold I, et al. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int J Pharm 2012;439:49–62.
   PubMed Web of Science ®Google Scholar
• Silva A, González-Mira E, García M, et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces 2011;86:158–65.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Kanaujia P, et al. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surfaces B Biointerfaces 2011;88:483–9.
   PubMed Web of Science ®Google Scholar
• Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 2004;4:484–8.
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2012;64:213–22.
   Web of Science ®Google Scholar
• Ambruosi A, Yamamoto H, Kreuter J. Body distribution of polysorbate‐80 and doxorubicin-loaded [14C] poly (butyl cyanoacrylate) nanoparticles after iv administration in rats. J Drug Target 2005;13:535–42.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Chandrasekar D, Ramakrishna S, et al. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm 2007;335:167–75.
   PubMed Web of Science ®Google Scholar
• Kim JK, Park JS, Kim CK. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm 2010;383:209–15.
   PubMed Web of Science ®Google Scholar
• Dodiya SS, Chavhan SS, Sawant KK, Korde AG. Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies. J Microencapsul 2011;28:515–27.
   PubMed Web of Science ®Google Scholar
• Gulyaev AE, Gelperina SE, Skidan IN, et al. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 1999;16:1564–9.
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. Poly (n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res 2008;1200:159–68.
   PubMed Web of Science ®Google Scholar
• Gelperina S, Maksimenko O, Khalansky A, et al. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. Eur J Pharm Biopharm 2010;74:157–63.
   PubMed Web of Science ®Google Scholar
• Alyautdin R, Tezikov E, Ramge P, et al. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J Microencapsul 1998;15:67–74.
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010;9:615–27.
   PubMed Web of Science ®Google Scholar
• Löbenberg R, Araujo L, von Briesen H, et al. Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after iv injection to rats. J Control Release 1998;50:21–30.
   PubMed Web of Science ®Google Scholar
• Chiannilkulchai N, Ammoury N, Caillou B, et al. Hepatic tissue distribution of doxorubicin-loaded nanoparticles after iv administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemotherapy Pharmacol 1990;26:122–6.
   PubMed Web of Science ®Google Scholar
• Ahsan F, Rivas IP, Khan MA, Suarez AIT. Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. J Control Release 2002;79:29–40.
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Gu W, et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009;30:226–32.
   PubMed Web of Science ®Google Scholar
• Araujo L, Löbenberg R, Kreuter J. Influence of the surfactant concentration on the body distribution of nanoparticles. J Drug Target 1999;6:373–85.
   PubMed Web of Science ®Google Scholar
• Liu M, Li H, Luo G, et al. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch Pharmacal Res 2008;31:547–54.
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93–102.
   PubMed Web of Science ®Google Scholar
• Saxena V, Sadoqi M, Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm 2006;308:200–4.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta 2009;1788:2259–66.
   PubMed Web of Science ®Google Scholar
• Gaur U, Sahoo SK, De Tapas K, et al. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 2000;202:1–10.
   PubMed Web of Science ®Google Scholar
• Hans M, Lowman A. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319–27.
   Web of Science ®Google Scholar
• Tsai YM, Chien CF, Lin LC, Tsai TH. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 2011;416:331–8.
   PubMed Web of Science ®Google Scholar